Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma. [electronic resource]
Producer: 20160517Description: 140 p. digitalISSN:- 1476-4598
- Adenocarcinoma -- complications
- Adenocarcinoma of Lung
- Animals
- Bevacizumab -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- complications
- Cell Line, Tumor
- Disease Models, Animal
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Lung Neoplasms -- complications
- Mice
- Plasminogen Activator Inhibitor 1 -- biosynthesis
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Venous Thromboembolism -- chemically induced
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.